http://pharmtech.findpharma.com/pharmtech/News/Article/list/35097 The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries. Trends & international news from global correspondents and breakthroughs in research in Coming Down the Pike. 2009-11-21T20:47:25Z http://pharmtech.findpharma.com/pharmtech/Manufacturing/Right-first-time-drug-manufacture/ArticleStandard/Article/detail/642528?contextCategoryId=35097&ref=25 Engineers at a UK university claim to have developed technology that can be used in existing chemical reactors to ensure right first time drug crystal formation, which is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations. 2009-11-20T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642528null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Fifty-Percent-of-MS-Patients-Avoid-Treatment-Over-/ArticleStandard/Article/detail/642553?contextCategoryId=35097&ref=25 Around half of all multiple sclerosis (MS) patients that are eligible for treatment do not receive it and one in five of those patients that do begin therapy, delay doing so because of fear and anxiety over the treatment process, and not fear and anxiety about the disease. 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642553null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/GSK-Donates-Influenza-A-H1N1-Vaccine-to-WHO/ArticleStandard/Article/detail/642555?contextCategoryId=35097&ref=25 Last week, GlaxoSmithKline (GSK, London) agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO). 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642555null HTML http://pharmtech.findpharma.com/pharmtech/News/Rx-360-Takes-on-Europe-Talks-to-PharmTech-About-Sh/ArticleStandard/Article/detail/642579?contextCategoryId=35097&ref=25 The international pharmaceutical supply-chain consortium Rx-360 held a launch meeting in Europe last week with more than 135 industry and regulatory representatives in attendance. 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642579null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-Announces-RampD-Facility-Consolidation/ArticleStandard/Article/detail/642582?contextCategoryId=35097&ref=25 Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities. 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642582null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-Updates-Vaccine-Progress-in-Germany-Acqui/ArticleStandard/Article/detail/640743?contextCategoryId=35097&ref=25 Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640743null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/EU-Issues-Strategy-for-Influenza-A-H1N1-Vaccine-Be/ArticleStandard/Article/detail/640749?contextCategoryId=35097&ref=25 The European Medicines Agency, the European Center for Disease Prevention and Control, and the Heads of Medicines Agencies issued a European strategy for H1N1 vaccine benefit–risk monitoring. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640749null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/PhRMA-Reacts-to-House-Healthcare-Reform-Bill/ArticleStandard/Article/detail/640751?contextCategoryId=35097&ref=25 On Sunday, Nov. 8, 2009, the Pharmaceutical Research and Manufacturers of America (PhRMA) expressed its disappointment with the US House of Representatives's healthcare-reform bill. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640751null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=35097&ref=25 The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/UK-Backs-Continuous-Processing/ArticleStandard/Article/detail/640757?contextCategoryId=35097&ref=25 A consortium led by GlaxoSmithKline (UK) intends to deliver a "step change improvement" in pharmaceutical tablet manufacturing in the UK by "substantially" increasing the country's manufacturing efficiency. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640757null HTML http://pharmtech.findpharma.com/pharmtech/News/New-speciality-pharma-company-formed-in-Sweden/ArticleStandard/Article/detail/639927?contextCategoryId=35097&ref=25 A new pharmaceutical company with a focus on rare diseases has been formed in Sweden following the merger of the Swedish companies Biovitrum and Swedish Orphan. 2009-11-06T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639927null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-To-Invest-1-Billion-in-China-RampD-Instit/ArticleStandard/Article/detail/638992?contextCategoryId=35097&ref=25 Novartis (Basel, Switzerland) plans to invest $1 billion over the next five years to increase research and development activities in China, including a significant expansion of The Novartis Institute of BioMedical Research (CNIBR) in Shanghai. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638992null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?contextCategoryId=35097&ref=25 Last week, the steering committee and expert working groups of the International Conference on Harmonization (ICH) met in St. Louis, Missouri. A major success of the meeting was the adoption of several annexes to ICH Q4B on pharmacopeial texts. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638997null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Lonza-Restructures-Plans-Cost-Reductions/ArticleStandard/Article/detail/639210?contextCategoryId=35097&ref=25 Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to 18 months. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639210null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=35097&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and Drug Administration responded to the association's citizen petition relating to the inspection process of foreign drug-manufacturing facilities. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639211null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Europe-May-See-10-New-Orphan-Products-a-Year/ArticleStandard/Article/detail/638999?contextCategoryId=35097&ref=25 The European Organization for Rare Diseases (EURORDIS) predicts that 100 new designated orphan products will receive marketing authorization between 2009 and 2019, which equates to approximately 10 new products every year. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638999null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?contextCategoryId=35097&ref=25 In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639036null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?contextCategoryId=35097&ref=25 Cargill has recently announced a number of innovations connected to its range of polyol excipients. 2009-10-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637079null HTML http://pharmtech.findpharma.com/pharmtech/Most+Viewed+Articles/Pfizer-accused-of-corporate-arrogance/ArticleStandard/Article/detail/637074?contextCategoryId=35097&ref=25 A complaint submitted to the Federal Trade Commission has referred to Pfizer's acquisition of Wyeth as "potentially monopolistic" and has urged the Commission to see that "the proposed merger is not in the public interest and is in conflict with a wide range of President Obama's objectives". 2009-10-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637074null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?contextCategoryId=35097&ref=25 An inhaler mouthpiece that optimizes drug delivery to the lungs and reduces the amount of wasted medication has been developed by US researchers. 2009-10-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637068null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Generic-APIs-Outstrip-Innovation/ArticleStandard/Article/detail/637179?contextCategoryId=35097&ref=25 The global API market has expanded from $69 billion in 2004 to more than $90 billion in 2008, according to a report from the Italian Chemical Pharmaceutical Association (CPA); in particular, the report noted a rapid growth rate for generic APIs. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637179null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/House-Committee-Passes-IST-Requirements-in-Chemica/ArticleStandard/Article/detail/637178?contextCategoryId=35097&ref=25 The House Energy and Commerce Committee approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009," a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) program. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637178null HTML http://pharmtech.findpharma.com/pharmtech/News/GAO-Report-Calls-Out-FDAs-Poor-Oversight-of-Accele/ArticleStandard/Article/detail/637175?contextCategoryId=35097&ref=25 The US Food and Drug Administration needs to enhance its oversight of drugs approved on the basis of surrogate endpoints, according to a September report from the Government Accountability Office (GAO) that was released this week. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637175null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Tracks-Influenza-A-Treatment-with-Prescription/ArticleStandard/Article/detail/637177?contextCategoryId=35097&ref=25 The US Food and Drug Administration is using prescription data from Wolters Kluwer Pharma Solutions to track the treatment of influenza A (H1N1) and other influenza viruses, according to a statement that the company released last week. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637177null HTML http://pharmtech.findpharma.com/pharmtech/News/Generics-prevent-innovations-in-pharma/ArticleStandard/Article/detail/635260?contextCategoryId=35097&ref=25 Cheaper generic pharmaceuticals, emboldened by US law and patent challenges, restrict novel future innovations. 2009-10-23T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635260null HTML http://pharmtech.findpharma.com/pharmtech/News/Uniting-all-CROs/ArticleStandard/Article/detail/635281?contextCategoryId=35097&ref=25 US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help companies get products to market faster by establishing an international network of CROs. 2009-10-23T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635281null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-New-Guidance-on-Drug-Labeling-and-Pharm/ArticleStandard/Article/detail/635534?contextCategoryId=35097&ref=25 The US Food and Drug Administration issued a guidance for industry and review staff titled, Labeling for Human Prescription Drug and Biological Products-Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635534null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?contextCategoryId=35097&ref=25 Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635536null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/EFCG-Counterfeit-Medicines-More-Profitable-than-He/ArticleStandard/Article/detail/635540?contextCategoryId=35097&ref=25 The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635540null HTML http://pharmtech.findpharma.com/pharmtech/News/SAFC-announces-12-million-expansion-to-Carlsbad-fa/ArticleStandard/Article/detail/634067?contextCategoryId=35097&ref=25 SAFC Pharma has completed a $12-million expansion to its contract manufacturing facility in Carlsbad (CA, USA), which will expand the company's services for its later phase and commercial clients. 2009-10-16T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/634067null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/IMS-Raises-Global-Pharma-Market-Growth-Forecast/ArticleStandard/Article/detail/633983?contextCategoryId=35097&ref=25 IMS Health delivered some good news last week with its updated pharmaceutical market forecast. 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633983null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Cancer-Drugs-Account-for-5-of-Overall-Drug-Spendin/ArticleStandard/Article/detail/633985?contextCategoryId=35097&ref=25 For the first time, cancer treatments accounted for 5% of overall drug spending in the first half of 2009, said Medco Health Solutions in a press release last week. 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633985null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Issues-New-Quality-Standards-for-Heparin/ArticleStandard/Article/detail/632148?contextCategoryId=35097&ref=25 The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632148null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Releases-Draft-Guidance-for-REMS/ArticleStandard/Article/detail/632127?contextCategoryId=35097&ref=25 The US Food and Drug Administration published its first draft guidance for industry about Risk Evaluation and Mitigation Strategies (REMS) on Sept. 30, 2009. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632127null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Companies-Update-Pandemic-H1N1-Flu-Vaccine-Project/ArticleStandard/Article/detail/632147?contextCategoryId=35097&ref=25 GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632147null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Nobel-Prize-Awarded-for-Research-in-the-Role-of-a-/ArticleStandard/Article/detail/632128?contextCategoryId=35097&ref=25 The 2009 Nobel Prize in Physiology or Medicine was awarded to three US researchers for the discovery of how chromosomes are protected from degradation by telomeres and the enzyme telomerase during cell division. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632128null HTML http://pharmtech.findpharma.com/pharmtech/News/EMEA-to-fully-implement-Product-Information-Manage/ArticleStandard/Article/detail/630111?contextCategoryId=35097&ref=25 The EMEA intends to fully implement its Product Information Management (PIM) approach, an initiative designed to improve information management, into the centralized procedure within 2 years, according to a statement of intent from the agency. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630111null HTML http://pharmtech.findpharma.com/pharmtech/News/500-jobs-created-by-Almac-expansion/ArticleStandard/Article/detail/630113?contextCategoryId=35097&ref=25 Almac's expansion plans in Northern Ireland (UK) could see the creation of more than 500 jobs during the next 5 years. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630113null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Biotech-is-Uneven-in-New-EU-Member-States/ArticleStandard/Article/detail/630297?contextCategoryId=35097&ref=25 A new report evaluating the biotechnology sector in new European Union member states and candidate countries has described biotech developments as "uneven" because of contrasting economic strategies in different countries. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630297null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Abbott-to-Acquire-Solvay-Pharmaceuticals-for-66-Bi/ArticleStandard/Article/detail/630294?contextCategoryId=35097&ref=25 Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630294null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-Proposed-Rule-on-CGMPs-for-Combination-/ArticleStandard/Article/detail/630291?contextCategoryId=35097&ref=25 The US Food and Drug Administration issued a proposed rule to clarify the current good manufacturing practice (CGMP) requirements applicable to combination products in the Sept. 23 Federal Register. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630291null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/EMEA-Recommends-Two-H1N1-Vaccines-for-Authorizatio/ArticleStandard/Article/detail/630295?contextCategoryId=35097&ref=25 On September 25, the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommended the authorization of two vaccines for use in Europe against the H1N1 influenza: GlaxoSmithKline's (GSK) Pandemrix and Novartis's Focetria. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630295null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Seattle-Genetics-Introduces-Sugar-Engineered-Antib/ArticleStandard/Article/detail/630293?contextCategoryId=35097&ref=25 The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630293null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Vaccines-for-low-income-countries/ArticleStandard/Article/detail/628275?contextCategoryId=35097&ref=25 A joint venture between a charity and a pharma giant has led to the creation of the Hilleman Laboratories, which will use a not-for-profit operating model to develop and deliver vaccines to low-income countries. 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628275null HTML http://pharmtech.findpharma.com/pharmtech/News/Vetter-to-open-new-US-facility/ArticleStandard/Article/detail/628521?contextCategoryId=35097&ref=25 Vetter (Germany) is intending to open a technologically advanced customer services facility at the end of 2009 in Chicago (US). 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628521null HTML http://pharmtech.findpharma.com/pharmtech/News/New-pharma-plastic-centers-opened/ArticleStandard/Article/detail/628519?contextCategoryId=35097&ref=25 The Gerresheimer Group is opening two new centres: an R&D center for medical plastic systems in the US and a new production center for pharmaceutical plastic packaging in Spain. 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628519null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Bayer-Receives-Warning-Letter-for-Alleged-Deviatio/ArticleStandard/Article/detail/628581?contextCategoryId=35097&ref=25 The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs). 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628581null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-to-Hold-Public-Hearing-on-Online-Drug-Promotio/ArticleStandard/Article/detail/628580?contextCategoryId=35097&ref=25 The US Food and Drug Administration plans to hold a public hearing to discuss the promotion of agency-regulated drugs and medical devices on the Internet and using social media tools, according to a notice in the Sept. 21, 2009, Federal Register. 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628580null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pharma-Goes-Back-to-Basics-to-Battle-Recession/ArticleStandard/Article/detail/628611?contextCategoryId=35097&ref=25 Many pharmaceutical companies in the United Kingdom are turning to basic business-skills training to help them emerge from the recession stronger than before. 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628611null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/EMEA-Report-Issues-Urgent-Call-for-New-Antibiotics/ArticleStandard/Article/detail/628607?contextCategoryId=35097&ref=25 A report from the European Medicines Agency (EMEA) has highlighted the critical fact that there are not enough new antibiotics in the pharmaceutical industry's pipeline to fight multidrug-resistant bacteria. 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628607null HTML http://pharmtech.findpharma.com/pharmtech/News/Current-pharma-model-irrelevant/ArticleStandard/Article/detail/626797?contextCategoryId=35097&ref=25 The current pharmaceutical model is in danger of becoming "irrelevant in the context of 21st century's global healthcare needs", according to a white paper published by global management consultancy firm A.T. Kearney. 2009-09-18T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626797null HTML http://pharmtech.findpharma.com/pharmtech/News/Developing-flow-chemistry-for-pharma/ArticleStandard/Article/detail/626805?contextCategoryId=35097&ref=25 AM Technology (UK) has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds. 2009-09-18T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626805null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Single-Dose-H1N1-Vaccines-Get-FDA-OK/ArticleStandard/Article/detail/626907?contextCategoryId=35097&ref=25 The US Food and Drug Administration has approved four vaccines for the H1N1 influenza virus, while other companies, including GlaxoSmithKline (GSK), have reported promising results from clinical studies with a single dose vaccine. 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626907null HTML http://pharmtech.findpharma.com/pharmtech/News/FDAs-Sharfstein-Outlines-Principles-of-Public-Heal/ArticleStandard/Article/detail/626933?contextCategoryId=35097&ref=25 Speaking to the audience of the 2009 PDA-FDA Joint Regulatory Conference in Washington, DC, this week, US Food and Drug Administration Principal Deputy Commissioner outlined four principles that define FDA's role as a public health agency. 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626933null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Scientists-Discover-RNA-Interference-in-Budding-Ye/ArticleStandard/Article/detail/626931?contextCategoryId=35097&ref=25 Vaccine makers and other pharmaceutical manufacturers using yeast protein-expression systems are taking note of a discovery this week by a team of researchers who have found RNA interference in Saccharomyces castellii. 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626931null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/Senate-Finance-Committee-Introduces-Latest-Legisla/ArticleStandard/Article/detail/626927?contextCategoryId=35097&ref=25 The Senate Finance Committee through its chairman, Max Baucus (D-MT), introduced on Sept. 16, 2009, a bill, "America's Healthy Future Act of 2009," representing the latest Congressional proposal for healthcare reform. 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626927null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Lilly-Announces-Reorganization/ArticleStandard/Article/detail/626929?contextCategoryId=35097&ref=25 Eli Lilly and Company (Indianapolis, IN) is undergoing a companywide reorganization that is intended to accelerate the progress of the company's pipeline. 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626929null HTML http://pharmtech.findpharma.com/pharmtech/News/Pfizer-takes-23-billion-hit/ArticleStandard/Article/detail/624857?contextCategoryId=35097&ref=25 Pfizer will pay $2.3 billion to settle the investigation with the US Department of Justice regarding the off-label promotion of Bextra. 2009-09-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624857null HTML http://pharmtech.findpharma.com/pharmtech/News/EMEA-mandates-electronic-submissions-by-1-January-/ArticleStandard/Article/detail/624855?contextCategoryId=35097&ref=25 The European Medicines Agency (EMEA) has issued a reminder that the Electronic Common Technical Document (e-CTD) format will be mandatory for marketing authorization applications for medicinal products for human use from 1 January 2010. 2009-09-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624855null HTML http://pharmtech.findpharma.com/pharmtech/News/Encaps-deal-to-target-colonic-drug-delivery/ArticleStandard/Article/detail/624872?contextCategoryId=35097&ref=25 Encap Drug Delivery (UK) has licensed a coating technology that targets the release of drugs to the colon. 2009-09-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624872null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/EC-Backs-Nanotechnology-with-EUR-1-Billion/ArticleStandard/Article/detail/624981?contextCategoryId=35097&ref=25 The European Commission (EC) has made EUR 1 billion available for new projects involving micro and nanotechnology. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624981null HTML http://pharmtech.findpharma.com/pharmtech/News/FDA-Seeks-Data-for-Sentinel-Initiative/ArticleStandard/Article/detail/624929?contextCategoryId=35097&ref=25 The US Food and Drug Administration plans to begin collecting information for its Sentinel Initiative, according to a Sept. 4 Federal Register announcement. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624929null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Dainippon-Sumitomo-Pharma-to-Acquire-Sepracor/ArticleStandard/Article/detail/624972?contextCategoryId=35097&ref=25 In move designed to increase its position in North America, Dainippon Sumitomo Pharma (DSP, Osaka, Japan) has agreed to acquire the specialty pharmaceutical company Sepracor (Marlborough, MA) for $2.6 billion. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624972null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Controlled-Release-Formulations-a-Popular-Strategy/ArticleStandard/Article/detail/624970?contextCategoryId=35097&ref=25 Generic-drug companies are increasingly viewing the development of controlled-release formulations as a way of obtaining a competitive edge, according to a report published by Espicom Business Intelligence in late August 2009. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624970null HTML http://pharmtech.findpharma.com/pharmtech/News/FDA-Most-Firms-Meeting-Postmarketing-Study-Timelin/ArticleStandard/Article/detail/624982?contextCategoryId=35097&ref=25 More than 80% of pharmaceutical and biologics companies are completing their postmarketing studies and regulatory obligations in a timely manner. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624982null HTML http://pharmtech.findpharma.com/pharmtech/News/WITNESS-software-leads-to-success-for-Sanofi/ArticleStandard/Article/detail/623497?contextCategoryId=35097&ref=25 Sanofi aventis has finished implementing Lanner's process simulation software into one of its major UK sites following a successful Phase I implementation in which the company made more than £1 million in inventory cost savings in 6 months. 2009-09-04T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623497null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/USP-to-Develop-Standards-with-Mexican-Commission/ArticleStandard/Article/detail/623593?contextCategoryId=35097&ref=25 The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623593null HTML http://pharmtech.findpharma.com/pharmtech/Online+Only/QampA-With-Compliance-Expert-Barbara-Jentges/ArticleStandard/Article/detail/623590?contextCategoryId=35097&ref=25 Later this month, Dr. Barbara Jentges, the managing director at PhACT GmbH, a regulatory consulting and training firm based in Duggingen, Switzerland, will be speaking at the 2nd Vetter Drug Management Leadership Conference in Germany. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623590null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Merck-Lays-Out-New-Management-and-Organizational-S/ArticleStandard/Article/detail/623597?contextCategoryId=35097&ref=25 Merck & Co. (Whitehouse Station, NJ) outlined a new organizational structure and named top management and senior leaders for the company, effective upon the completion of its merger with Schering-Plough (Kenilworth, NJ). 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623597null HTML http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Final-Guidance-on-OTC-Drug-Labeling/ArticleStandard/Article/detail/623595?contextCategoryId=35097&ref=25 The US Food and Drug Administration last week issued the final draft of its guidance for industry titled Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions and Answers. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623595null HTML http://pharmtech.findpharma.com/pharmtech/Online+Only/REACH-Program-May-Carry-Six-Times-the-Expected-Cos/ArticleStandard/Article/detail/623599?contextCategoryId=35097&ref=25 Implementing Europe's Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) program, will require a massive increase in animal testing and cost six times more than previously estimated. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623599null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/One-Shot-H1N1-Vaccine-Gets-Chinese-Thumbs-Up/ArticleStandard/Article/detail/623600?contextCategoryId=35097&ref=25 An H1N1 vaccine developed by biopharmaceutical company Sinovac Biotech (Beijing, China) has passed the experts evaluation organized by the Chinese State Food and Drug Administration (SFDA) and the company is expected to obtain a production license before the week's end. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623600null HTML http://pharmtech.findpharma.com/pharmtech/News/Sigma-Aldrich-to-distribute-knockout-rodents/ArticleStandard/Article/detail/621501?contextCategoryId=35097&ref=25 Scientists at Sigma-Aldrich's new Sigma Advanced Genetic Engineering Labs in St Louis (MO, USA) will develop and distribute genetically engineered animal models for use in research. 2009-08-28T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621501null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Opens-Center-for-Tobacco-Products/ArticleStandard/Article/detail/621585?contextCategoryId=35097&ref=25 On Aug. 19, 2009, the US Food and Drug Administration opened a new Center for Tobacco Products on the agency's White Oak Campus in Silver Spring, Maryland. 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621585null HTML http://pharmtech.findpharma.com/pharmtech/Outsourcing/Pharma-Boom-in-Eastern-Europe/ArticleStandard/Article/detail/621589?contextCategoryId=35097&ref=25 Eastern Europe's pharmaceutical market is forecast to grow at a CAGR of more than 10% to be worth more than $41 billion by 2014, according to a report from companiesandmarkets.com. 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621589null HTML http://pharmtech.findpharma.com/pharmtech/News/Electronic-Safety-Reporting-May-Soon-Be-Mandatory-/ArticleStandard/Article/detail/621583?contextCategoryId=35097&ref=25 The US Food and Drug Administration announced in an Aug. 20, 2009 release that it would like to amend postmarket safety reporting regulations "to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format." 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621583null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Major-Shareholder-Rejects-Lonza-Bid-for-Patheon/ArticleStandard/Article/detail/621590?contextCategoryId=35097&ref=25 Lonza (Basel) has submitted a non-binding proposal that would see it acquire all of the Restricted Voting Shares of US-based Patheon. 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621590null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Tobacco-Plant-Helps-Sprout-Norovirus-Vaccine/ArticleStandard/Article/detail/621586?contextCategoryId=35097&ref=25 Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes called the "cruise ship virus." 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621586null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Craig-Venters-Team-Reports-Key-Advance-in-Syntheti/ArticleStandard/Article/detail/621588?contextCategoryId=35097&ref=25 Researchers at the J. Craig Venter Institute (JCVI), a genomic research organization, reported that they successfully transformed one bacterium into a different strain by transferring the entire bacterial genome of the first strain into a second, related strain of bacteria. 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621588null HTML http://pharmtech.findpharma.com/pharmtech/News/Partnership-for-improved-systems-integration/ArticleStandard/Article/detail/621496?contextCategoryId=35097&ref=25 A transatlantic strategic partnership has been struck between California (USA) based enterprise software solution provider ValGenesis and IT integration specialists Systec & Services (Germany). 2009-08-26T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621496null HTML http://pharmtech.findpharma.com/pharmtech/News/FDA-urged-to-demand-greater-transparency/ArticleStandard/Article/detail/620049?contextCategoryId=35097&ref=25 Researchers from a university in the US are urging the FDA to demand that drug manufacturers state how new medications compare with similar treatments on product labels. 2009-08-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620049null HTML http://pharmtech.findpharma.com/pharmtech/News/Amcor-makes-a-move-for-Alcan-Packaging/ArticleStandard/Article/detail/620052?contextCategoryId=35097&ref=25 Amcor (Australia) has made an offer of $2025 million for parts of Alcan Packaging (France), including the company's global pharmaceuticals division. 2009-08-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620052null HTML http://pharmtech.findpharma.com/pharmtech/News/Businesses-neglect-to-measure-value-of-outsourcing/ArticleStandard/Article/detail/620047?contextCategoryId=35097&ref=25 Only 43% of European Chief Financial Officers (CFOs) and Chief Information Officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident in their sums, according to a study by Cognizant. 2009-08-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620047null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Researchers-Develop-First-Aptamer-Liposome-Deliver/ArticleStandard/Article/detail/620135?contextCategoryId=35097&ref=25 Researchers at the University of Illinois (Champaign) have developed a cancer drug delivery system that reportedly kills target tumor cells, spars healthy cells, and has effects that can be reversed to halt potentially hazardous side effects. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620135null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Report-Predicts-Growth-for-Outsourcing-to-India/ArticleStandard/Article/detail/620132?contextCategoryId=35097&ref=25 India accounts for approximately 3% of the global outsourcing market, which indicates a significant opportunity for growth, according to a report published by Ernst and Young and the Organization of Pharmaceutical Producers of India. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620132null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Industry-Considers-Green-Chemistry-Standards/ArticleStandard/Article/detail/620134?contextCategoryId=35097&ref=25 An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620134null HTML http://pharmtech.findpharma.com/pharmtech/News/Academia-Urges-More-Transparency-on-Labels/ArticleStandard/Article/detail/620133?contextCategoryId=35097&ref=25 Researchers from the Stanford University School of Medicine in California are urging the US Food and Drug Administration to demand that drug manufacturers state how new medications compare with similar treatments on product labels. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620133null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/Warning-Letter-Enforcement-Begins-in-September/ArticleStandard/Article/detail/620130?contextCategoryId=35097&ref=25 The US Food and Drug Administration announced a new program regarding the issuance of warning letters to the pharmaceutical industry. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620130null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/UK-Researchers-Target-Marine-Microbes-for-Green-Ma/ArticleStandard/Article/detail/618414?contextCategoryId=35097&ref=25 Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618414null HTML http://pharmtech.findpharma.com/pharmtech/News/European-Businesses-Neglect-to-Measure-Value-of-Ou/ArticleStandard/Article/detail/620136?contextCategoryId=35097&ref=25 Only 43% of European chief financial officers (CFOs) and chief information officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident about their calculations, according to a study by Cognizant, a global business technology company based in Teaneck, NJ. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620136null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Companies-Update-Activities-for-Pandemic-and-Seaso/ArticleStandard/Article/detail/618411?contextCategoryId=35097&ref=25 Baxter International (Deerfield, IL), sanofi aventis (Paris), and Novartis (Basel, Switzerland) provided updates last week of their production and regulatory activities relating to preparedness in supplying the A(H1N1) pandemic influenza vaccine. Novartis also outlined its activities for providing seasonal flu vaccines. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618411null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/BIO-Asks-Supreme-Court-to-Overturn-iBilskii-Ruling/ArticleStandard/Article/detail/618408?contextCategoryId=35097&ref=25 On August 6, the Biotechnology Industry Organization (BIO) filed an amicus brief asking the US Supreme Court to overturn Bilski v. Doll, a decision of the US Court of Appeals for the Federal Circuit. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618408null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/FDA-Issues-Guidance-on-Monitoring-At-Risk-Melamine/ArticleStandard/Article/detail/618407?contextCategoryId=35097&ref=25 The US Food and Drug Administration released its Guidance for Industry titled Pharmaceutical Components at Risk for Melamine Contamination. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618407null HTML http://pharmtech.findpharma.com/pharmtech/News/FDA-Commissioner-Outlines-Six-Step-Plan-for-Improv/ArticleStandard/Article/detail/618409?contextCategoryId=35097&ref=25 US Food and Drug Administration Commissioner Margaret Hamburg outlined last week six initial steps designed to improve the effectiveness and timeliness of FDA's regulatory and enforcement system. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618409null HTML http://pharmtech.findpharma.com/pharmtech/News/Pfizer-Vs-Nigerias-Kano-State-case-comes-to-a-clos/ArticleStandard/Article/detail/619144?contextCategoryId=35097&ref=25 An agreement has been reached between Pfizer and Nigeria's Kano State government following the long-running Trovan trial, which stems from the accusation that Pfizer illegally tested the antibiotic Trovan (trovafloxacin) on children in 1996 during a meningitis outbreak. 2009-08-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/619144null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-and-FDA-To-Collaborate-on-Good-Clinical-Pract/ArticleStandard/Article/detail/616595?contextCategoryId=35097&ref=25 The US Food and Drug Administration and European Medicines Agency (EMEA) launched this week a joint initiative to collaborate on international good clinical practice (GCP) inspection activities. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616595null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/House-Healthcare-Reform-Bill-Includes-Eshoo-Amendm/ArticleStandard/Article/detail/616598?contextCategoryId=35097&ref=25 The Energy and Commerce Committee of the US House of Representatives approved H.R. 3200, America's Affordable Health Choices Act, last Friday. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616598null HTML http://pharmtech.findpharma.com/pharmtech/News/String-of-attacks-aimed-at-Novartis-CEO/ArticleStandard/Article/detail/619137?contextCategoryId=35097&ref=25 Novartis has confirmed that the ashes of CEO Daniel Vasella's mother have been stolen and his holiday home set fire to. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/619137null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/EU-Issues-Study-on-REACH-Implementation/ArticleStandard/Article/detail/616591?contextCategoryId=35097&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) reported in late July that Eurostat, the Statistical Office of the European Communities, recently published a baseline study or the first snapshot of REACH policy in the preregistration phase. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616591null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FY-2010-User-Fees-Released/ArticleStandard/Article/detail/616582?contextCategoryId=35097&ref=25 The US Food and Drug Administration announced its prescription drug user fee rates for fiscal year 2010 in the August 3 Federal Register. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616582null HTML